Anticipating oral mucositis in oral cancer patients undergoing fractionated radiotherapy

A cytological correlation

Nidhi Manaktala, Karen Boaz, Srikant Natarajan, Amitha Lewis, K. P. Nandita, Manish Juneja, K. Jairama Shetty

Research output: Contribution to journalArticle

Abstract

Oral mucositis is one of the most common side effects of fractionated radiation therapy. Along with clinical changes, radiation also induces cytological changes which include both cytoplasmic as well as nuclear alterations. The present study was carried out todocument and correlate theclinical and cytological changes in the oral epithelial cells of patients undergoing fractionated radiation therapy for head and neck malignancies. 24 patients undergoing fractionated radiotherapy for head and neck malignancies were selected and observed during the course of therapy for development of clinical changes like erythema, ulceration and trismus. Simultaneously smears from oral mucosa were taken and studied for increase in cell size, cytoplasmic changes like granularity, vacuolization and fragmentation and nuclear changes like micronuclei, binucleation and multinucleation. Significant linear dose dependant correlation was seen between the radiation doses and clinical and cytological changes. The present study is critical in its method to predict the development of erythema and ulceration by assessing genotoxic cellular markers like micronuclei, binucleation and multinucleation which are direct indicators of molecular changes. As these markers correlate well with the molecular changes, namely the reactive oxygen species (ROS), nuclear factor kappa β (NF-kβ) and cytokines, the treatment regime to improve control of pain and irritation during mucositis can be planned more efficiently.

Original languageEnglish
Pages (from-to)294-301
Number of pages8
JournalResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Volume6
Issue number3
Publication statusPublished - 01-01-2015

Fingerprint

Stomatitis
Mouth Neoplasms
Radiotherapy
Erythema
Dosimetry
Neck
Head
Trismus
Radiation
Mucositis
Mouth Mucosa
Cell Size
Reactive Oxygen Species
Neoplasms
Epithelial Cells
Cytokines
Pain
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{04a7755538f641dca029fe1745d36f14,
title = "Anticipating oral mucositis in oral cancer patients undergoing fractionated radiotherapy: A cytological correlation",
abstract = "Oral mucositis is one of the most common side effects of fractionated radiation therapy. Along with clinical changes, radiation also induces cytological changes which include both cytoplasmic as well as nuclear alterations. The present study was carried out todocument and correlate theclinical and cytological changes in the oral epithelial cells of patients undergoing fractionated radiation therapy for head and neck malignancies. 24 patients undergoing fractionated radiotherapy for head and neck malignancies were selected and observed during the course of therapy for development of clinical changes like erythema, ulceration and trismus. Simultaneously smears from oral mucosa were taken and studied for increase in cell size, cytoplasmic changes like granularity, vacuolization and fragmentation and nuclear changes like micronuclei, binucleation and multinucleation. Significant linear dose dependant correlation was seen between the radiation doses and clinical and cytological changes. The present study is critical in its method to predict the development of erythema and ulceration by assessing genotoxic cellular markers like micronuclei, binucleation and multinucleation which are direct indicators of molecular changes. As these markers correlate well with the molecular changes, namely the reactive oxygen species (ROS), nuclear factor kappa β (NF-kβ) and cytokines, the treatment regime to improve control of pain and irritation during mucositis can be planned more efficiently.",
author = "Nidhi Manaktala and Karen Boaz and Srikant Natarajan and Amitha Lewis and Nandita, {K. P.} and Manish Juneja and {Jairama Shetty}, K.",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "6",
pages = "294--301",
journal = "Research Journal of Pharmaceutical, Biological and Chemical Sciences",
issn = "0975-8585",
publisher = "RJPBCS",
number = "3",

}

Anticipating oral mucositis in oral cancer patients undergoing fractionated radiotherapy : A cytological correlation. / Manaktala, Nidhi; Boaz, Karen; Natarajan, Srikant; Lewis, Amitha; Nandita, K. P.; Juneja, Manish; Jairama Shetty, K.

In: Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 6, No. 3, 01.01.2015, p. 294-301.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anticipating oral mucositis in oral cancer patients undergoing fractionated radiotherapy

T2 - A cytological correlation

AU - Manaktala, Nidhi

AU - Boaz, Karen

AU - Natarajan, Srikant

AU - Lewis, Amitha

AU - Nandita, K. P.

AU - Juneja, Manish

AU - Jairama Shetty, K.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Oral mucositis is one of the most common side effects of fractionated radiation therapy. Along with clinical changes, radiation also induces cytological changes which include both cytoplasmic as well as nuclear alterations. The present study was carried out todocument and correlate theclinical and cytological changes in the oral epithelial cells of patients undergoing fractionated radiation therapy for head and neck malignancies. 24 patients undergoing fractionated radiotherapy for head and neck malignancies were selected and observed during the course of therapy for development of clinical changes like erythema, ulceration and trismus. Simultaneously smears from oral mucosa were taken and studied for increase in cell size, cytoplasmic changes like granularity, vacuolization and fragmentation and nuclear changes like micronuclei, binucleation and multinucleation. Significant linear dose dependant correlation was seen between the radiation doses and clinical and cytological changes. The present study is critical in its method to predict the development of erythema and ulceration by assessing genotoxic cellular markers like micronuclei, binucleation and multinucleation which are direct indicators of molecular changes. As these markers correlate well with the molecular changes, namely the reactive oxygen species (ROS), nuclear factor kappa β (NF-kβ) and cytokines, the treatment regime to improve control of pain and irritation during mucositis can be planned more efficiently.

AB - Oral mucositis is one of the most common side effects of fractionated radiation therapy. Along with clinical changes, radiation also induces cytological changes which include both cytoplasmic as well as nuclear alterations. The present study was carried out todocument and correlate theclinical and cytological changes in the oral epithelial cells of patients undergoing fractionated radiation therapy for head and neck malignancies. 24 patients undergoing fractionated radiotherapy for head and neck malignancies were selected and observed during the course of therapy for development of clinical changes like erythema, ulceration and trismus. Simultaneously smears from oral mucosa were taken and studied for increase in cell size, cytoplasmic changes like granularity, vacuolization and fragmentation and nuclear changes like micronuclei, binucleation and multinucleation. Significant linear dose dependant correlation was seen between the radiation doses and clinical and cytological changes. The present study is critical in its method to predict the development of erythema and ulceration by assessing genotoxic cellular markers like micronuclei, binucleation and multinucleation which are direct indicators of molecular changes. As these markers correlate well with the molecular changes, namely the reactive oxygen species (ROS), nuclear factor kappa β (NF-kβ) and cytokines, the treatment regime to improve control of pain and irritation during mucositis can be planned more efficiently.

UR - http://www.scopus.com/inward/record.url?scp=84938770080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938770080&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 294

EP - 301

JO - Research Journal of Pharmaceutical, Biological and Chemical Sciences

JF - Research Journal of Pharmaceutical, Biological and Chemical Sciences

SN - 0975-8585

IS - 3

ER -